Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 11, 2022 (Week 23)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 119 471 5,974 3,773 6 14 136 87
New England 2 21 266 151 - 1 1 -
Connecticut - 6 29 38 - 0 - -
Maine 2 7 49 34 - 0 - -
Massachusetts - 10 124 51 - 0 - -
New Hampshire - 4 32 15 - 1 1 -
Rhode Island - 4 21 9 - 1 - -
Vermont - 3 11 4 - 0 - -
Middle Atlantic 36 85 917 515 3 6 33 23
New Jersey 4 12 92 95 1 3 16 16
New York (excluding New York City) 14 45 350 149 1 2 7 -
New York City 11 22 202 136 - 6 - 7
Pennsylvania 7 22 273 135 1 2 10 -
East North Central 3 94 1,099 554 - 4 38 11
Illinois N NC N N N NC N N
Indiana 1 27 226 174 - 0 - -
Michigan - 20 218 124 - 2 4 4
Ohio - 41 488 248 - 4 34 7
Wisconsin 2 19 167 8 - 0 - -
West North Central 3 32 353 182 - 2 13 22
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri - 20 227 118 - 2 13 13
Nebraska 3 7 58 28 - 0 - -
North Dakota - 4 23 14 - 0 - -
South Dakota - 7 45 22 - 1 - 9
South Atlantic 26 74 695 671 1 5 13 7
Delaware - 5 43 25 - 0 - -
District of Columbia - 2 15 8 - 0 - -
Florida 18 26 308 241 1 3 10 5
Georgia - 18 34 207 - 0 - -
Maryland 8 11 43 87 - 0 - 1
North Carolina N NC N N N NC N N
South Carolina - 25 181 13 - 3 1 1
Virginia - 2 6 7 - 0 - -
West Virginia - 11 65 83 - 2 2 -
East South Central 4 45 525 433 - 2 2 2
Alabama - 19 151 118 - 1 1 -
Kentucky - 12 91 50 - 2 1 2
Mississippi 3 6 79 66 - 0 - -
Tennessee 1 28 204 199 - 0 - -
West South Central 2 141 637 499 - 5 13 15
Arkansas 2 10 102 58 - 1 1 -
Louisiana - 11 69 144 - 2 2 -
Oklahoma N NC N N N NC N N
Texas - 131 466 297 - 5 10 15
Mountain 41 94 1,386 705 2 3 17 7
Arizona 14 48 593 308 - 1 4 3
Colorado 18 28 356 136 - 1 2 -
Idaho N NC N N N NC N N
Montana - 5 36 28 - 1 - -
Nevada 1 10 115 81 - 1 1 2
New Mexico 4 16 179 70 - 0 - -
Utah 4 12 107 61 2 2 10 2
Wyoming - 3 - 21 - 0 - -
Pacific 2 12 96 63 - 2 6 -
Alaska 2 11 85 52 - 2 6 -
California N NC N N N NC N N
Hawaii - 3 11 11 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 119 471 5,974 3,774 6 14 136 87
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.